Evolent Health (EVH) Invested Capital (2015 - 2026)

Evolent Health has reported Invested Capital for 12 years, with the latest figure at $1.3 billion in Q2 2026.

• On a quarterly basis, Invested Capital fell 28.54% year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $1.3 billion, a 28.54% decrease from a year earlier, with the FY2025 full-year figure at $1.4 billion, down 24.47% from the prior year.
• Invested Capital was $1.3 billion for Q2 2026 at Evolent Health, down from $1.4 billion in the prior quarter.
• The five-year high for Invested Capital was $1.9 billion in Q1 2025, with the low at $893.8 million in Q1 2022.
• Average Invested Capital over 5 years is $1.5 billion, with a median of $1.6 billion recorded in 2024.
• The sharpest annual moves came in 2023 and 2026: Invested Capital soared 96.24% in 2023, then dropped 28.9% in 2026.
• Over 5 years, Invested Capital stood at $1.3 billion in 2022, then surged by 30.84% to $1.7 billion in 2023, then gained by 10.21% to $1.8 billion in 2024, then dropped by 24.47% to $1.4 billion in 2025, then declined by 2.6% to $1.3 billion in 2026.
• The last three Invested Capital figures came in at $1.3 billion (Q2 2026), $1.4 billion (Q1 2026), and $1.4 billion (Q4 2025), per Business Quant data.